Smiths Group PLC Total Voting Rights

RNS Number : 5396C

Smiths Group PLC

02 September 2024

 

2 SEPTEMBER 2024

 

SMITHS GROUP PLC

 

TOTAL VOTING RIGHTS AND CAPITAL

 

At close of business on 30 August 2024 the issued share capital of Smiths Group plc comprised 344,699,518 Ordinary shares of nominal value 37.5p each ('Ordinary Shares'), all of which have been admitted to the Official List of the Financial Conduct Authority ('FCA') and admitted to trading on the London Stock Exchange.  

 

Each Ordinary Share has one vote on a poll. Smiths Group plc does not hold any shares in treasury.

 

Therefore, the total number of voting rights in Smiths Group plc is 344,699,518 which should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the share capital of Smiths Group plc under the FCA's Disclosure Guidance and Transparency Rules.

 

The total number of voting rights confirmed in this announcement does not reflect the shares purchased on 29 and 30 August 2024 under the Share Buyback Programme which have yet to settle and be cancelled.

 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

 

Enquiries:

Matthew Whyte, Group Company Secretary

Smiths Group plc

[phone]

[phone]

[e-mail]

 

 

 

About Smiths Group

 

For over 170 years, Smiths Group has been pioneering progress by improving the world through smarter engineering. We serve millions of people every year, to help create a safer, more efficient and better-connected world, across four major global markets:  Energy, General Industry, Security & Defence, and Aerospace. Listed on the London Stock Exchange, Smiths employs c. 15,000 colleagues in over 50 countries. For more information visit www.smiths.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

TVRBLLFBZKLBBBB